The Double Marker Test is a pivotal screening tool in prenatal care, analyzing specific substances in the mother's blood to assess the risk of chromosomal abnormalities in the fetus. Conducted between the 11th and 14th weeks of pregnancy, understanding its significance empowers expectant parents to make informed decisions about their baby's health